Skip to main content

Table 3 Top 10 compounds predicted to have activity against JSpA as predicted via connectivity map

From: Identifying circRNA-associated-ceRNA networks in juvenile spondyloarthropathies patients

ID

Cmap name

Dose

Cell

Score

Description

Target

BRD-K73794685

azithromycin

0.125 μm

THP1

-0.45

Bacterial 50 S ribosomal subunit inhibitor

MLNR

BRD-K59037100

oxybenzone

0.125 μm

THP1

-0.44

Lipase inhibitor

LIPE

BRD-A68009927

daunorubicin

0.08 μm

THP1

-0.43

RNA synthesis inhibitor |Topoisomerase inhibitor

TOP2A|TOP2B

BRD-K76205745

losartan

0.25 μm

THP1

-0.43

Angiotensin receptor antagonist

AGTR1

BRD-K93208532

apremilast

2.22 μm

THP1

-0.43

Phosphodiesterase inhibitor

PDE4A|PDE4B|PDE4C|PDE4D|TNF|TNFRSF1A

BRD-K49055432

A-66

0.04 μm

THP1

-0.42

PI3K inhibitor

PIK3CA

BRD-K64990520

apocynin

0.74 μm

THP1

-0.42

NADPH inhibitor

NOX3|NOX4

BRD-K89732114

trifluoperazine

10 μm

THP1

-0.41

Dopamine receptor antagonist

DRD2|ABCG2|CAMK2A|SCN4A|SCN9A|ADRA1A|CALM1|CALY|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1

BRD-A49399758

desmopressin-acetate

0.37 μm

THP1

-0.41

Vasopressin receptor agonist

AVPR2|AVPR1A|AVPR1B|OXTR

BRD-K59715032

pasireotide

10 μm

THP1

-0.4

Somatostatin receptor agonist

SSTR1|SSTR2|SSTR3|SSTR5|GH1